<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04037631</url>
  </required_header>
  <id_info>
    <org_study_id>AT-LISA-tri 839MP BER-401-17</org_study_id>
    <nct_id>NCT04037631</nct_id>
  </id_info>
  <brief_title>Compare Visual Outcomes Using a New Diagnostic Device</brief_title>
  <official_title>Prospective Clinical Study to Compare Visual Performance Obtained With a New Diagnostic Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carl Zeiss Meditec AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carl Zeiss Meditec AG</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of preoperative corrected distance visual acuity (CDVA) obtained with VirtIOL
      device compared to postoperative CDVA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 20, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Corrected distance visual acuity (CDVA)</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Evaluation of CDVA obtained with diagnostic device</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Patients without clinically significant age-related cataract</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Diagnostic device</intervention_name>
    <description>Diagnostic test</description>
    <arm_group_label>Patients without clinically significant age-related cataract</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients without clinically significant age-related cataract
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient informed of the consequences and constraints of the protocol and who has given
             his/her written informed consent

          -  Patients of any gender, aged 18 years to open age

          -  Assured follow-up examinations

          -  Healthy eyes without clinically significant age-related cataract

             -Exclusion Criteria:

          -  Patients unable to meet the limitations of the protocol or likely of non-cooperation
             during the trial

          -  Patients whose freedom is impaired by administrative or legal order

          -  Concurrent participation in another drug or device investigation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>CZM CA</last_name>
    <phone>+49308540010</phone>
    <email>clinicalstudies.meditec.sur@zeiss.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Internationale Innovative Ophthalmologie</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40549</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hakan Kaymak</last_name>
      <phone>0211 586757-0</phone>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 26, 2019</study_first_submitted>
  <study_first_submitted_qc>July 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2019</study_first_posted>
  <last_update_submitted>December 2, 2019</last_update_submitted>
  <last_update_submitted_qc>December 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

